Quality of Life, Blood Transfusions, and Toxicity, in Anemic Patients with Advanced Cancer Receiving Weekly Erythropoietin While on Chemotherapy: Results from a Phase III Randomized Double-Blind Placebo-Controlled Study.

Reviewer: Ryan Smith, MD
OncoLink
Ultima Vez Modificado: 7 de diciembre del 2002

Translation for this article does not exist

Frequently Asked Questions